For Immediate Release
Chicago, IL – September 28, 2016 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include General Electric (NYSE:GE) (NYSE:GE-Free Report),GlaxoSmithKline (NYSE:GSK-Free Report) and McDonald (NYSE: MCD- Free Report).
Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.
Here are highlights from Tuesday’s Analyst Blog:
New Research Reports from General Electric, McDonalds and GlaxoSmithKline
We are featuring 16 research reports on major stocks in today's Research Daily, including General Electric (NYSE:GE-Free Report), GlaxoSmithKline (NYSE:GSK-Free Report) and McDonald’s (NYSE:MCD- Free Report).
Buy rated General Electric shares have lagged the market this year on concerns about the conglomerate's order backlog and continued weakness in the energy end-market. This issue notwithstanding, the company has done an excellent job of its plan to reduce its exposure to finance and get back to its industrial and engineering roots. To that end, it is enjoying strong momentum in the power and aviation end markets, partly offset by continued weakness in the energy space. A track record of returning excess cash to shareholders through buybacks and dividends (dividend yields an attractive 3.1%) are some of the other positives in the GE story. (You can read the full research report on GE here>>)
GlaxoSmithKline shares have gained more than 7% year-to-date, outperforming many of its large-cap pharma peers. The buy rated stock is positioned to deliver strong core earnings growth on the back of performance momentum in its new products as well as those acquired from Novartis. These should help support revenues and ease the impact of the loss of Advair sales. Glaxo’s efforts to develop its pipeline are also encouraging. Moreover, steps to increase cost efficiency and its outlook for the next five years bode well. You can read the full research report on GlaxoSmithKline here>> )
McDonald’s shares have been weak lately on soft industry trends, macroeconomic concerns in various parts of the world along with negative currency translation issues. However, the analyst likes the manner in which McDonald’s has turned itself around in the domestic market like menu innovation, introduction of value meals, efficient marketing and promotions, and improved service. (You canread the full research report on McDonald’s here >>)
Other noteworthy reports we are featuring today include Caterpillar (NYSE:CAT) and Medtronic (NYSE:MDT).
Free Access: All Zacks Research Reports
Starting today, you are invited to download in-depth analysis reports covering more than 1,000 of the most widely followed stocks. Valued at $25 each, they are yours to consult over the next 30 days absolutely free. They feature sensitive Zacks Rank information on each stock that you won't find anywhere else. See the reports free >>
You can find all of today's stock research reports here>>
Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today.
About Zacks
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros.
Get the full Report on GE - FREE
Get the full Report on GSK - FREE
Get the full Report on MCD - FREE
Follow us on Twitter: https://twitter.com/zacksresearch
Join us on Facebook: https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
GENL ELECTRIC (GE): Free Stock Analysis Report
GLAXOSMITHKLINE (GSK): Free Stock Analysis Report
MCDONALDS CORP (MCD): Free Stock Analysis Report
Original post